Related Experiment Videos
[The correlation between Chlamydiae pneumonia and carotid atherosclerosis]
Zhi-wei Tang1, Xiang-en Shi, Yong-kai Chang
1Department of Neurosurgery, Fuxing Hospital, the Capital Medical University, Beijing 100038, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|August 21, 2013
Summary
Chlamydia pneumoniae infection is linked to carotid atherosclerosis. Further research suggests a potential connection between this infection and cerebral ischemic events, highlighting its role in vascular disease.
Area of Science:
- Infectious Disease Epidemiology
- Cardiovascular Pathology
- Neuroscience
Context:
- Carotid atherosclerosis is a significant risk factor for ischemic stroke.
- Chlamydia pneumoniae is a known pathogen implicated in various inflammatory conditions.
- The role of infectious agents in the development and progression of atherosclerosis remains an active area of research.
Purpose:
- To investigate the association between Chlamydia pneumoniae infection and the presence of carotid atherosclerosis.
- To explore the correlation between Chlamydia pneumoniae infection and the occurrence of ischemic events in patients with carotid atherosclerosis.
Summary:
- Chlamydia pneumoniae was detected in 9 out of 19 atherosclerotic carotid plaques, significantly more than in control arterial tissues (P = 0.011).
- In patients with carotid atherosclerosis, Chlamydia pneumoniae was found in 9 out of 15 individuals who experienced ischemic events, suggesting a possible link.
- Immunohistochemistry revealed co-localization of Chlamydia pneumoniae with markers of inflammation, including Toll-like receptor 2 (TLR2), tumor necrosis factor-α (TNF-α), and vascular cell adhesion molecule-1 (VCAM-1) within atherosclerotic plaques.
Impact:
- This study provides evidence supporting a correlation between Chlamydia pneumoniae infection and carotid atherosclerosis.
- The findings suggest a potential role for Chlamydia pneumoniae infection in the pathogenesis of cerebral ischemic events.
- Further investigation into the mechanisms underlying this association could lead to novel therapeutic strategies for preventing atherosclerosis and stroke.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...